日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site

通过靶向变构位点抑制结核分枝杆菌 CoaBC

Vitor Mendes, Simon R Green, Joanna C Evans, Jeannine Hess, Michal Blaszczyk, Christina Spry, Owain Bryant, James Cory-Wright, Daniel S-H Chan, Pedro H M Torres, Zhe Wang, Navid Nahiyaan, Sandra O'Neill, Sebastian Damerow, John Post, Tracy Bayliss, Sasha L Lynch, Anthony G Coyne, Peter C Ray, Chris

Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis

结核分枝杆菌对吲哚 4-甲酰胺的耐药性是通过药物代谢和色氨酸生物合成的改变而发生的

M Daben J Libardo, Caroline J Duncombe, Simon R Green, Paul G Wyatt, Stephen Thompson, Peter C Ray, Thomas R Ioerger, Sangmi Oh, Michael B Goodwin, Helena I M Boshoff, Clifton E Barry 3rd

Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity

通过化学抑制 4'-磷酸泛酰-l-半胱氨酸合成酶 (CoaB) 活性来靶向结核分枝杆菌 CoaBC

Joanna C Evans, Dinakaran Murugesan, John M Post, Vitor Mendes, Zhe Wang, Navid Nahiyaan, Sasha L Lynch, Stephen Thompson, Simon R Green, Peter C Ray, Jeannine Hess, Christina Spry, Anthony G Coyne, Chris Abell, Helena I M Boshoff, Paul G Wyatt, Kyu Y Rhee, Tom L Blundell, Clifton E Barry 3rd, Valer

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

具有改进的 hERG 和细胞毒性特征的 Spirocycle MmpL3 抑制剂可作为结核分枝杆菌生长的抑制剂

Peter C Ray, Margaret Huggett, Penelope A Turner, Malcolm Taylor, Laura A T Cleghorn, Julie Early, Anuradha Kumar, Shilah A Bonnett, Lindsay Flint, Douglas Joerss, James Johnson, Aaron Korkegian, Steven Mullen, Abraham L Moure, Susan H Davis, Dinakaran Murugesan, Michael Mathieson, Nicola Caldwell,